Rating Indicators
VERU Stock: Few Reasons To Be Better
Veru Inc. (NASDAQ: VERU) revealed the findings of phase III trials of antiviral medication for patients with severe COVID-19. In clinical studies, the sabizabulin candidate
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.